SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-17-035275
Filing Date
2017-06-30
Accepted
2017-06-30 17:04:37
Documents
3
Group Members
BRIAN STRAUSSDR. WILLIAM KAYRICHARD D. HORNIDGE, JR.RICHARD KWAKROBERT DAVISRON HIRSCHIRONALD K. TOLBOETED KUSTIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v470186_sc13d.htm SC 13D 217061
2 EXHIBIT 1 v470186_ex-1.htm EX-99.1 6940
3 EXHIBIT 2 v470186_ex-2.htm EX-99.2 11197
  Complete submission text file 0001144204-17-035275.txt   236864
Mailing Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824
Business Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824 (203) 368-6044
CALMARE THERAPEUTICS Inc (Subject) CIK: 0000102198 (see all company filings)

IRS No.: 362664428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-30128 | Film No.: 17942982
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 160 RIO KOBLES SAN JOSE CA 95130
Business Address
YARBRO STAN (Filed by) CIK: 0001269921 (see all company filings)

Type: SC 13D